ID   LCL 721
AC   CVCL_2102
SY   LCL-721; 721; 721 LCL; B-LCL 721; LCL721
DR   BTO; BTO:0006531
DR   dbMHC; 48948
DR   ECACC; 09071301
DR   IHW; IHW09249
DR   IPD-IMGT/HLA; 10972
DR   Wikidata; Q54902205
RX   PubMed=6933474;
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*01:01:01:01,02:01:01:01; B*08:01:01,51:01:01; C*07:01:01,01:02:01; DPA1*01:03,02:01:02; DPB1*02:01:02,04:01; DQB1*05:01:01; DRB1*01:01 (IPD-IMGT/HLA=10972).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 17
//
RX   PubMed=6933474; DOI=10.1073/pnas.77.7.4251;
RA   Kavathas P.B., Bach F.H., DeMars R.I.;
RT   "Gamma ray-induced loss of expression of HLA and glyoxalase I alleles
RT   in lymphoblastoid cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 77:4251-4255(1980).
//
RX   PubMed=30844424; DOI=10.1016/j.humimm.2019.03.001;
RA   Creary L.E., Guerra S.G., Chong W., Brown C.J., Turner T.R.,
RA   Robinson J., Bultitude W.P., Mayor N.P., Marsh S.G.E., Saito K.,
RA   Lam K., Duke J.L., Mosbruger T.L., Ferriola D., Monos D.S., Willis A.,
RA   Askar M., Fischer G.F., Saw C.L., Ragoussis J., Petrek M.,
RA   Serra-Pages C., Juan Otero M., Stavropoulos-Giokas C., Dinou A., Ameen R.,
RA   Al Shemmari S., Spierings E., Gendzekhadze K., Morris G.P., Zhang Q.-H.,
RA   Kashi Z., Hsu S., Gangavarapu S., Mallempati K.C., Yamamoto F.,
RA   Osoegawa K., Vayntrub T., Chang C.-J., Hansen J.A.,
RA   Fernandez-Vina M.A.;
RT   "Next-generation HLA typing of 382 International Histocompatibility
RT   Working Group reference B-lymphoblastoid cell lines: report from the
RT   17th International HLA and Immunogenetics Workshop.";
RL   Hum. Immunol. 80:449-460(2019).
//